Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASP3 | P42574 | 19/20 | 0.68 |
| ▸ | CASP7 | P55210 | 18/20 | 0.68 |
| ▸ | CASP9 | P55211 | 1/20 | 0.68 |
| ▸ | CASP1 | P29466 | 3/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8307728 | 1.00 | CASP3 (0.68) | CASP3CASP7CASP9CASP1 | |
| SCHEMBL5339051 | 0.86 | CASP3 (0.66) | CASP3CASP7CASP9CASP1 | |
| SCHEMBL6954700 | 0.86 | CASP3 (0.49) | CASP3CASP7CASP9CASP1 | |
| SCHEMBL8307047 | 0.86 | CASP3 (0.49) | CASP3CASP7CASP9CASP1 | |
| SCHEMBL5337430 | 0.85 | CASP3 (0.62) | CASP3CASP7CASP9CASP1 | |
| SCHEMBL5333108 | 0.85 | CASP3 (0.62) | CASP3CASP7CASP9CASP1 | |
| SCHEMBL7804480 | 0.82 | CASP3 (0.49) | CASP3CASP7CASP9CASP1 | |
| SCHEMBL7433422 | 0.81 | PSEN1 (0.56) | CASP3CASP7CASP9 | |
| SCHEMBL7440426 | 0.81 | CASP3 (0.51) | CASP3CASP7CASP9CASP1 | |
| SCHEMBL3681388 | 0.81 | CASP3 (1.00) | CASP3CASP7CASP9CASP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0988035-B1 | CASPASES AND APOPTOSIS | SMITHKLINE BEECHAM CORP (US) | 2003-05-02 | — | — | EP | claimed |
| US-6214858-B1 | PREVENTING AND TREATING EXCESSIVE CELL DEATH USING OXINDOLE DERIVATIVES | SMITHKLINE BEECHAM CORPORATION | 2001-04-10 | — | — | US | claimed |
| EP-0988035-B1 | CASPASES AND APOPTOSIS | SMITHKLINE BEECHAM CORP (US) | 2003-05-02 | — | — | EP | disclosed |
| EP-0988035-A4 | CASPASES AND APOPTOSIS | SMITHKLINE BECKMAN CORP (US) | 2001-09-19 | — | — | EP | disclosed |
| US-6214858-B1 | PREVENTING AND TREATING EXCESSIVE CELL DEATH USING OXINDOLE DERIVATIVES | SMITHKLINE BEECHAM CORPORATION | 2001-04-10 | — | — | US | disclosed |
| EP-0988035-A1 | CASPASES AND APOPTOSIS | SMITHKLINE BEECHAM CORPORATION (US) | 2000-03-29 | — | — | EP | disclosed |
| WO-1999006042-A1 | CASPASES AND APOPTOSIS | SMITHKLINE BEECHAM CORPORATION (US) | 1999-02-11 | — | — | WO | disclosed |